Eupraxia Pharmaceuticals Inc.
EPRXNasdaqCIK 1581178HealthcareFiscal year ends Dec 31
Reports and events: 94 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2212:50 ET | 6-K | Report of a foreign private issuerPeriod 2026-10-22 | 0001171843-26-006756 |
| 2026-10-1514:13 ET | 6-K | Report of a foreign private issuerPeriod 2026-10-15 | 0001171843-26-006648 |
| 2026-10-0912:27 ET | 6-K | Report of a foreign private issuerPeriod 2026-10-09 | 0001171843-26-006551 |
| 2026-09-3012:04 ET | 6-K | Report of a foreign private issuerPeriod 2026-09-30 | 0001171843-26-006307 |
| 2026-09-0812:05 ET | 6-K | Report of a foreign private issuerPeriod 2026-09-08 | 0001171843-26-005913 |
| 2026-08-1312:10 ET | 6-K | Report of a foreign private issuerPeriod 2026-08-13 | 0001171843-26-005479 |
| 2026-08-1121:24 ET | 6-K | Report of a foreign private issuerPeriod 2026-08-11 | 0001193125-26-345045 |
| 2026-07-1517:26 ET | 6-K | Report of a foreign private issuerPeriod 2026-07-15 | 0001171843-26-004676 |
| 2026-07-1320:15 ET | 6-K | Report of a foreign private issuerPeriod 2026-07-13 | 0001171843-26-004605 |
| 2026-07-0720:20 ET | 6-K | Report of a foreign private issuerPeriod 2026-07-07 | 0001171843-26-004516 |
| 2026-06-2215:03 ET | 6-K | Report of a foreign private issuerPeriod 2026-06-19 | 0001171843-26-004213 |
| 2026-05-2918:17 ET | 6-K | Report of a foreign private issuerPeriod 2026-06-18 | 0001171843-26-003787 |
| 2026-05-2918:09 ET | 6-K | Report of a foreign private issuerPeriod 2026-05-28 | 0001171843-26-003785 |
| 2026-05-2820:24 ET | 6-K | Report of a foreign private issuerPeriod 2026-05-28 | 0001171843-26-003762 |
| 2026-05-1221:06 ET | 6-K | Report of a foreign private issuerPeriod 2026-05-12 | 0001193125-26-219802 |
| 2026-05-0611:00 ET | 6-K | Report of a foreign private issuerPeriod 2026-05-06 | 0001171843-26-003051 |
| 2026-05-0511:00 ET | 6-K | Report of a foreign private issuerPeriod 2026-05-05 | 0001171843-26-003003 |
| 2026-05-0121:23 ET | 6-K | Report of a foreign private issuerPeriod 2026-05-01 | 0001171843-26-002939 |
| 2026-04-2211:00 ET | 6-K | Report of a foreign private issuerPeriod 2026-04-22 | 0001171843-26-002633 |
| 2026-04-2114:43 ET | 6-K | Report of a foreign private issuerPeriod 2026-04-21 | 0001171843-26-002597 |
| 2026-04-1523:12 ET | 6-K | Report of a foreign private issuerPeriod 2026-04-14 | 0001171843-26-002448 |
| 2026-04-1522:34 ET | 6-K | Report of a foreign private issuerPeriod 2026-04-14 | 0001193125-26-155275 |
| 2026-03-1711:00 ET | 6-K | Report of a foreign private issuerPeriod 2026-03-17 | 0001171843-26-001612 |
| 2026-03-1601:56 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-108982 |
| 2026-03-1301:18 ET | 40-F | Annual report of a Canadian issuerPeriod 2025-12-31 | 0001193125-26-104765 |
| 2026-03-0618:57 ET | 6-K | Report of a foreign private issuerPeriod 2026-02-23 | 0001193125-26-096039 |
| 2026-02-2020:21 ET | 6-K | Report of a foreign private issuerPeriod 2026-02-20 | 0001171843-26-000978 |
| 2026-02-2022:53 ET | 6-K | Report of a foreign private issuerPeriod 2026-02-19 | 0001193125-26-059789 |
| 2026-02-1911:05 ET | 6-K | Report of a foreign private issuerPeriod 2026-02-19 | 0001171843-26-000911 |
| 2026-02-1822:05 ET | 6-K | Report of a foreign private issuerPeriod 2026-02-18 | 0001171843-26-000892 |
| 2026-01-0817:02 ET | 6-K | Report of a foreign private issuerPeriod 2026-01-08 | 0001171843-26-000141 |
| 2025-11-1322:00 ET | 6-K | Report of a foreign private issuerPeriod 2025-11-13 | 0001171843-25-007294 |
| 2025-11-0421:01 ET | 6-K | Report of a foreign private issuerPeriod 2025-11-04 | 0001193125-25-264619 |
| 2025-10-0114:56 ET | 6-K | Report of a foreign private issuerPeriod 2025-09-29 | 0001171843-25-006215 |
| 2025-09-2920:32 ET | 6-K | Report of a foreign private issuerPeriod 2025-09-29 | 0001193125-25-223295 |
| 2025-09-2601:19 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000899140-25-001145 |
| 2025-09-2415:12 ET | 6-K | Report of a foreign private issuerPeriod 2025-09-24 | 0001171843-25-006052 |
| 2025-09-2319:51 ET | 6-K | Report of a foreign private issuerPeriod 2025-09-23 | 0001193125-25-213247 |
| 2025-09-2315:07 ET | 6-K | Report of a foreign private issuerPeriod 2025-09-22 | 0001171843-25-006031 |
| 2025-09-2220:43 ET | 6-K | Report of a foreign private issuerPeriod 2025-09-22 | 0001171843-25-006011 |
| 2025-09-1919:53 ET | 6-K | Report of a foreign private issuerPeriod 2025-09-19 | 0001193125-25-209033 |
| 2025-09-0212:15 ET | 6-K | Report of a foreign private issuerPeriod 2025-09-02 | 0001171843-25-005662 |
| 2025-08-1322:03 ET | 6-K | Report of a foreign private issuerPeriod 2025-08-12 | 0001193125-25-179135 |
| 2025-07-2221:23 ET | 6-K | Report of a foreign private issuerPeriod 2025-07-22 | 0001171843-25-004613 |
| 2025-07-0811:00 ET | 6-K | Report of a foreign private issuerPeriod 2025-07-08 | 0001171843-25-004357 |
| 2025-06-0323:08 ET | 6-K | Report of a foreign private issuerPeriod 2025-06-02 | 0001171843-25-003581 |
| 2025-06-0222:00 ET | 6-K | Report of a foreign private issuerPeriod 2025-05-30 | 0001171843-25-003547 |
| 2025-05-0718:15 ET | 6-K | Report of a foreign private issuerPeriod 2025-05-07 | 0001171843-25-002894 |
| 2025-05-0620:59 ET | 6-K | Report of a foreign private issuerPeriod 2025-05-06 | 0001193125-25-113877 |
| 2025-05-0511:15 ET | 6-K | Report of a foreign private issuerPeriod 2025-05-05 | 0001171843-25-002740 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.